Bioelectronica Corporation Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2017

Location

Reno NV US

Primary Industry

Biotechnology

About

Founded in 2017 and based in Nevada, US, Bioelectronica Corporation is a biotechnology company for drug discovery, diagnostics, and cell sorting. The firm was founded by the CEO, Mr. Jonathan Hull. In February 2021, the firm has raised funding from Proxima Ventures and Co-win Ventures. Bioelectronica Corporation provides Hypercell®, a single-cell sorting system that combines computer vision, biochemical reagents, and consumer electronics for biochemistry transformation. The firm's platform identifies productive cells in antibody discovery and processes the development. The firm plans to use its Series A funding in February 2021 to expand its team and new applications of cell line development and antibody discovery for the Hypercell® platform.

Current Investors

Rising Tide Fund, Intuitive Private Equity, Co-Win Ventures

Request a demo to show more

Primary Industry

Biotechnology

Sub Industries

Bioinformatics, Biopharmaceuticals, Diagnostic, Medical & Imaging Laboratories, Oncology/Cancer Treatment

Website

www.bioelectronica.com

Company Stage

Series A

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.